Distribution of miRNA expression across human tissues
Open accessAbstract
We present a human miRNA tissue atlas by determining the abundance of 1997 miRNAs in 61 tissue biopsies of different organs from two individuals collected post-mortem. One thousand three hundred sixty-four miRNAs were discovered in at least one tissue, 143 were present in each tissue. To define the distribution of miRNAs, we utilized a tissue specificity index (TSI). The majority of miRNAs (82.9%) fell in a middle TSI range i.e. were neither specific for single tissues (TSI > 0.85) nor housekeeping miRNAs (TSI < 0.5). Nonetheless, we observed many different miRNAs and miRNA families that were predominantly expressed in certain tissues. Clustering of miRNA abundances revealed that tissues like several areas of the brain clustered together. Considering -3p and -5p mature forms we observed miR-150 with different tissue specificity. Analysis of additional lung and prostate biopsies indicated that inter-organism variability was significantly lower than inter-organ variability. Tissue-specific differences between the miRNA patterns appeared not to be significantly altered by storage as shown for heart and lung tissue. MiRNAs TSI values of human tissues were significantly (P = 10(-8)) correlated with those of rats; miRNAs that were highly abundant in certain human tissues were likewise abundant in according rat tissues. We implemented a web-based repository enabling scientists to access and browse the data (https://ccb-web.cs.uni-saarland.de/tissueatlas).
AI snapshot
Written from the paper’s full text.
TL;DR
This paper presents a human miRNA tissue atlas by profiling 1,997 mature miRNAs across 61 post-mortem tissue biopsies from two male individuals, with 1,364 miRNAs detected in at least one tissue and 143 detected in all tissues. It reports tissue-specific miRNA patterns, a web repository, and conserved tissue specificity between human and rat.
Key findings
- Of 1,997 mature miRNAs, 633 (31.7%) were not detected in any tested tissue; 1,364 were detected in at least one tissue, and 143 (10.5%) were found in all tissues.
- Most detected miRNAs had intermediate tissue specificity: 82.9% fell in a middle TSI range, neither tissue-specific (TSI > 0.85) nor housekeeping (TSI < 0.5); in quantile-normalized data, 83.7% of miRNAs in the first body and 88.8% in the second body had intermediate TSI values.
- Tissue-specific examples included miR-1–3p as the overall most tissue-specific miRNA, high in muscle and myocardium; miR-122–5p in liver, miR-7–5p in pituitary gland, miR-205–5p in skin, and miR-507/miR-514a-3p/miR-509–5p in testis.
- Human and rat tissue specificity was significantly correlated (TSI correlation 0.362, P = 9 × 10−8; permutation average correlation 0), and inter-individual variability was significantly lower than inter-organ variability in lung and prostate analyses (P < 10−16).
Methods
- Profiled 61 tissue biopsies from two male cadavers (65-year-old with multiple myeloma; 59-year-old with no signs of cancer) using Agilent SurePrint 8 × 60K Human V19 miRNA microarrays, covering 1,997 human miRNAs present in both miRBase V19 and V21.
- Pre-analytics included 44 tissue miRNomes for reproducibility and storage/degradation analyses, 16 additional normal lung biopsies from different individuals, and GEO datasets from normal gastric and prostate tissues.
- Calculated a tissue specificity index (TSI) for each miRNA, performed hierarchical clustering, miRNA family and co-expression analyses, and compared human TSI values with rat data from GEO series GSE52754; analyses used raw, quantile-normalized, and variance-stabilized normalized data.
Limitations
- The paper states that autopsy samples from only two male individuals provide only a snapshot of full miRNA expression variability, and that age, sex, and disease status can influence miRNA patterns.
- The authors state they cannot exclude that some tissue-specific miRNAs might be affected by sample degradation, although storage between 1 and 14 days at 4°C had limited overall impact on tissue miRNA patterns.
- The paper notes that microarray analysis cannot detect presently unknown miRNAs or miRNA isoforms, and that normalization choice can substantially influence results; these are stated limitations of the platform and analysis approach.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 34 cited sources checked · 0 supported · 0 flagged
- Findingown data
The overall most tissue-specific miRNA was miR-1-3p.
“The overall most tissue-specific miR-1–3p is presented in Figure 3.”
Quote in the paperNot a substantial claim - Findingown data
There is no significant difference in TSI values between -3p and -5p mature forms (P > 0.5 for both VSN- and quantile-normalized data).
“For both, TSI values based on VSN- and quantile-normalized data, we did not found significant differences between -3p and -5p forms (P > 0.5 in both cases).”
Quote in the paperSubstantial claim - Findingown data
Co-expression is frequently observed among mature members of specific miRNA families (e.g., mir-548).
“While we frequently observed co-expression among mature members of specific families (e.g. the mir-548 family)”
Quote in the paperNot a substantial claim - Findingown data
miR-507, miR-514a-3p and miR-509-5p were almost exclusively expressed in the testis samples.
“Another group of miRNAs, miR-507, miR-514a-3p and miR-509–5p was almost exclusively expressed in the testis samples.”
Quote in the paperNot a substantial claim - Findingown data
Five miRNAs had TSI values increased in lung tissue by at least 20%: hsa-miR-8069, hsa-miR-6821-5p, hsa-miR-4800-5p, hsa-miR-6775-5p, hsa-miR-5001-5p.
“Especially for five miRNAs we, however, calculated TSI values that are increased in lung tissue by at least 20%: hsa-miR-8069, hsa-miR-6821–5p, hsa-miR-4800–5p, hsa-miR-6775–5p, hsa-miR-5001–5p.”
Quote in the paperNot a substantial claim
- Findingown data
For single miRNAs, differences dependent on storage could be observed.
“For single miRNAs still differences dependent on the storage could be observed.”
Quote in the paperSubstantial claim - Findingown data
miR-449b-3p is expressed in spleen.
“miR-449b-3p in spleen”
Quote in the paperNot a substantial claim - Findingown data
Out of the remaining 1364 miRNAs, 143 (10.5%) were found in all tissues.
“Out of the remaining 1364 miRNAs, 143 (10.5%) were found in all tissues.”
Quote in the paperSubstantial claim - Findingown data
Low expression of miR-122-5p was identified in spleen, gall bladder and veins.
“Our study, however, also identified low expression of miR-122–5p in spleen, gall bladder and veins.”
Quote in the paperNot a substantial claim - Findingown data
The mir-506 family (18 members) generally shows high abundance in testis and lower expression in other tissues.
“Similarly, the mir-506 family with 18 family members showed generally a high abundance in testis tissue while they were less expressed in other tissues.”
Quote in the paperNot a substantial claim - Findingown data
Irrespective of the normalization technique, TSI values for miRNAs are higher than those known for mRNAs (7).
“Irrespective of the normalization technique we found higher TSI values for miRNAs as, e.g. known from mRNAs (7).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] source
Queued — the background check reaches it, usually within a day.
- Findingown data
For other tissues extracted from GEO, lower TSI values were observed.
“Also for the other tissues extracted from the GEO, which are also available on the tissue atlas web resource, lower TSI values were observed.”
Quote in the paperNot a substantial claim - Findingown data
MiRNAs that were highly abundant in certain human tissues were likewise abundant in corresponding rat tissues.
“miRNAs that were highly abundant in certain human tissues were likewise abundant in according rat tissues.”
Quote in the paperSubstantial claim - Findingown data
For the second body, one miRNA (miR-6089) showed TSI < 0.15.
“one miRNA (miR-6089) showed a TSI < 0.15”
Quote in the paperNot a substantial claim - Findingown data
Clustering of miRNA abundances revealed that tissues like several areas of the brain clustered together.
“Clustering of miRNA abundances revealed that tissues like several areas of the brain clustered together.”
Quote in the paperNot a substantial claim - Findingcitation
miR-122-5p is the highest expressed miRNA in the liver of both bodies.
“Consistent with Landgraf‘s results, we found miR-122–5p as highest expressed miRNA in the liver of both bodies.”
Quote in the paperNot a substantial claim - Findingown data
Considering -3p and -5p mature forms, miR-150 showed different tissue specificity.
“Considering -3p and -5p mature forms we observed miR-150 with different tissue specificity.”
Quote in the paperNot a substantial claim - Findingown data
Raw-, quantile- and VSN-normalized expression intensities for miR-1-3p match well across all different tissues.
“Raw-, quantile- and VSN-normalized expression intensities for this miRNA match well across all different tissues.”
Quote in the paperNot a substantial claim - Findingown data
For all these miRNAs and organs, TSI values in human and rat show an overall correlation of 0.362 (P = 9 × 10−8).
“For all these miRNAs and organs, we calculated the TSI values in human and rat, showing an overall correlation of 0.362 (P-value of 9 × 10−8).”
Quote in the paperSubstantial claim - Findingown data
The correlation of VSN-normalized TSI values with quantile-normalized TSI values was 0.88 (P < 10−10).
“The correlation of the VSN-normalized TSI values with the quantile-normalized TSI values was 0.88 (P < 10−10).”
Quote in the paperNot a substantial claim - Findingown data
The majority of miRNAs (82.9%) fell in a middle TSI range, neither specific for single tissues (TSI > 0.85) nor housekeeping miRNAs (TSI < 0.5).
“The majority of miRNAs (82.9%) fell in a middle TSI range i.e. were neither specific for single tissues (TSI > 0.85) nor housekeeping miRNAs (TSI < 0.5).”
Quote in the paperSubstantial claim - Findingown data
Inter-organism variability was significantly lower than inter-organ variability in additional lung and prostate biopsies.
“Analysis of additional lung and prostate biopsies indicated that inter-organism variability was significantly lower than inter-organ variability.”
Quote in the paperNot a substantial claim - Findingown data
In the second major cluster, the organs of the two individuals frequently did not cluster together.
“In the second cluster, the organs of the two individuals frequently did not cluster together (Figure 4A).”
Quote in the paperNot a substantial claim - Findingown data
For quantile- and VSN-normalized data, TSI values in 16 lung tissue biopsies from different individuals were significantly decreased (P < 10−16).
“For the quantile- and VSN-normalized data, we calculated significantly decreased TSI values in the individuals (P < 10−16).”
Quote in the paperSubstantial claim - Findingown data
143 miRNAs were present in each tissue.
“143 were present in each tissue.”
Quote in the paperNot a substantial claim - Findingown data
Two miRNAs, hsa-miR-548n and hsa-miR-548ap-5p, were overall higher or lower in all tissues of one of the two bodies, independent of normalization technique.
“Two miRNAs, hsa-miR-548n and hsa-miR-548ap-5p, fulfilled these stringent criteria.”
Quote in the paperNot a substantial claim - Findingown data
MiRNA TSI values of human tissues were significantly (P = 10−8) correlated with those of rats.
“MiRNAs TSI values of human tissues were significantly (P = 10−8) correlated with those of rats”
Quote in the paperNot a substantial claim - Findingown data
No time course could be recognized in the clustering pattern of the 16 time-point lung biopsies.
“Again, no time curse could be recognized in the clustering pattern.”
Quote in the paperSubstantial claim - Findingown data
miR-205-5p was exclusively expressed in skin.
“miR-122–5p, miR-7–5p and miR-205–5p were each exclusively expressed in liver, pituitary gland and skin, respectively.”
Quote in the paperNot a substantial claim - Findingown data
For the second body, 152 miRNAs showed TSI > 0.85.
“152 miRNAs a TSI > 0.85”
Quote in the paperNot a substantial claim - Findingown data
Out of 1997 mature miRNAs, 633 (31.7%) were not detected in any tested tissue by the applied microarray technology.
“Out of the 1997 different mature miRNAs, 633 (31.7%) were not detected in any of the tested tissues by the applied microarray technology.”
Quote in the paperSubstantial claim - Findingown data
miR-7-5p was exclusively expressed in pituitary gland.
“miR-122–5p, miR-7–5p and miR-205–5p were each exclusively expressed in liver, pituitary gland and skin, respectively.”
Quote in the paperNot a substantial claim - Findingown data
miR-449c-5p and miR-449b-5p are expressed in kidney and small intestine.
“miR-449c-5p and -449b-5p in kidney and small intestine”
Quote in the paperNot a substantial claim - Findingown data
The second main cluster exclusively contained all brain tissue samples of both bodies and nervous system related tissue, i.e. spinal cord and dura mater.
“The second cluster exclusively contained all brain tissue samples of both bodies and nervous system related tissue, i.e. spinal cord and dura mater.”
Quote in the paperNot a substantial claim - Findingown data
Examples of directly matching organ pairs include spleen, myocardium, muscle, pancreas, kidney, liver, stomach, skin, brain or spinal cord.
“Examples of directly matching pairs include the spleen, myocardium, muscle, pancreas, kidney, liver, stomach, skin, brain or spinal cord.”
Quote in the paperNot a substantial claim - Findingown data
Many different miRNAs and miRNA families were predominantly expressed in certain tissues.
“Nonetheless, we observed many different miRNAs and miRNA families that were predominantly expressed in certain tissues.”
Quote in the paperSubstantial claim - Findingown data
For the first body, only one miRNA (miR-3960) was ubiquitously expressed with TSI < 0.15.
“Only one miRNA (miR-3960) was ubiquitously expressed with a TSI < 0.15”
Quote in the paperNot a substantial claim - Findingown data
miR-1-3p is highly expressed in muscle and myocardium.
“The miRNA is high expressed in muscle and myocardium.”
Quote in the paperNot a substantial claim - Findingown data
The third main cluster contained thyroid, nerve, muscle, myocardium and colon each of both bodies.
“The third cluster contained thyroid, nerve, muscle, myocardium and colon each of both bodies.”
Quote in the paperNot a substantial claim - Findingown data
Using quantile-normalized data for the first body, 83.7% of all miRNAs showed intermediate TSI values ranging from 0.15 to 0.85.
“Using the quantile-normalized data for the first body, 83.7% of all miRNAs showed an average abundance throughout the tissues with intermediate TSI values ranging from 0.15 to 0.85”
Quote in the paperSubstantial claim - Findingown data
For the second body, 88.8% of all miRNAs showed intermediate TSI values.
“For the second body, 88.8% of all miRNAs showed intermediate TSI values”
Quote in the paperNot a substantial claim - Findingown data
A cluster of four miRNAs (miR-338-3p, miR-219a-5p, miR-124-3p and miR-9-5p) was specifically expressed in various brain tissues.
“Additionally, we found a cluster of four miRNAs specifically expressed in various brain tissues, i.e. miR-338–3p, miR-219a-5p, miR-124–3p and miR-9–5p.”
Quote in the paperNot a substantial claim - Findingown data
For the first body, 222 miRNAs showed highly tissue-specific expression with TSI > 0.85.
“222 miRNAs showed a highly tissue-specific expression with TSI > 0.85.”
Quote in the paperNot a substantial claim - Findingown data
For a lung tissue from a third individual, 16 time points between 0 and 96 h clustered well together with lung tissues from the second individual stored over 14 days.
“These biopsies clustered well together with the lung tissues from the second individual with storage time over 14 days.”
Quote in the paperSubstantial claim - Findingown data
The mir-449 family (five members) does not show a common tissue expression pattern.
“Other families, such as the mir-449 family with five members, did not show a common pattern in the different tissues”
Quote in the paperNot a substantial claim - Findingown data
In all cases where both -3p and -5p mature forms were tissue specific regardless of normalization, their tissue patterns matched.
“Having a detailed look at single miRNAs, we discovered that in all cases where -3p and -5p mature forms were tissue specific independent on the normalization technique the tissue patterns matched.”
Quote in the paperSubstantial claim - Findingown data
High expression of miR-1-3p, miR-133a-3p, miR-133b and miR-206 was found in myocard and muscle.
“We also found high expression of miR-1–3p, miR-133a-3p, miR-133b and miR-206 in myocard and muscle.”
Quote in the paperNot a substantial claim - Findingown data
When comparing their data to a dataset on 55 different rat tissues (GEO, 8), they confirmed conserved tissue-specific expression of several miRNAs, including miR-133b, miR-124 and miR-9.
“When we compared our data to a data set on 55 different rat tissues available at GEO database (8), we could confirm conserved tissue-specific expression of several miRNAs, including miR-133b, miR-124 and miR-9.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Minami, 2014, miRNA expression atlas in male rat, Sci. Data source
- Findingown data
1364 miRNAs were discovered in at least one tissue.
“One thousand three hundred sixty-four miRNAs were discovered in at least one tissue”
Quote in the paperNot a substantial claim - Findingown data
Tissue-specific differences between miRNA patterns appeared not to be significantly altered by storage, as shown for heart and lung tissue.
“Tissue-specific differences between the miRNA patterns appeared not to be significantly altered by storage as shown for heart and lung tissue.”
Quote in the paperNot a substantial claim - Findingown data
miR-122-5p was exclusively expressed in liver.
“miR-122–5p, miR-7–5p and miR-205–5p were each exclusively expressed in liver, pituitary gland and skin, respectively.”
Quote in the paperNot a substantial claim - Findingown data
miR-4312 is co-expressed with miRNAs from the let-7 family.
“For example, miR-4312 was co-expressed with miRNAs from the let-7 family.”
Quote in the paperNot a substantial claim - Findingown data
They found sub-networks with at least four participants.
“In addition to pair-wise interactions, we also found sub-networks with at least four participants.”
Quote in the paperNot a substantial claim - Findingown data
miR-449c-3p is specifically expressed in spleen tissue.
“MiR-449c-3p was expressed specifically in spleen tissue”
Quote in the paperNot a substantial claim - Findingown data
Correlations of miRNAs from different miRNA families were also found.
“we also found correlations of miRNAs from different miRNA families.”
Quote in the paperNot a substantial claim - Findingown data
Other organs were found in different clusters, e.g. the lung samples and the brain coverings dura mater and arachnoid mater.
“Other organs were found in different clusters, e.g. the lung samples and the brain coverings dura mater and arachnoid mater.”
Quote in the paperNot a substantial claim - Findingown data
Permutation tests (1 million) showed an average correlation value of 0.
“To determine the significance of this finding, we additionally performed 1 million permutation tests, which showed an average correlation value of 0.”
Quote in the paperSubstantial claim - Findingown data
The best matching -3p/-5p profiles were found for hsa-miR-140, hsa-miR-378a, hsa-miR-509, hsa-miR-122, hsa-miR-124, hsa-miR-192 and hsa-miR-455.
“The best matching profiles were found for hsa-miR-140, hsa-miR-378a, hsa-miR-509, hsa-miR-122, hsa-miR-124, hsa-miR-192 and hsa-miR-455.”
Quote in the paperNot a substantial claim - Findingown data
They provide an atlas of miRNA expression in multiple human tissues.
“In summary, we provide an atlas of miRNA expression in multiple human tissues.”
Quote in the paperSubstantial claim- Rests on an assumption: The majority of studies investigate differential expression in only one organ/tissue.
- Rests on an assumption: Results of studies are not easily comparable due to different identification methods and normalization strategies, limiting their value for comparison of miRNA expression in different tissues.
- Study design and conductown data
The study profiled 1997 mature miRNAs in 61 tissue biopsies from two post-mortem individuals.
“We present a human miRNA tissue atlas by determining the abundance of 1997 miRNAs in 61 tissue biopsies of different organs from two individuals collected post-mortem.”
Quote in the paperSubstantial claim- Rests on an assumption: The two post-mortem male individuals are representative of the general human population for tissue miRNA distribution.
- Rests on an assumption: The first individual's multiple myeloma did not substantially alter the miRNA profiles of his non-tumor tissues.
- Rests on an assumption: RNA integrity values between 1.8 and 2.7 in autopsy samples are sufficient for reliable miRNA profiling.
- Premisenone given
There is a lack of up-to-date databases showing tissue-specific distribution of miRNAs.
“For the class of small non-coding nucleic acids, the so-called microRNAs or miRNAs, there is a lack of up-to-date databases showing their tissue-specific distribution.”
Quote in the paperSubstantial claim - Premisecitation
Landgraf et al. 2007 reported the first and most comprehensive analysis of miRNA abundance in different tissues.
“The first and as of now most comprehensive analysis of miRNA abundance in different tissues has been reported by Landgraf et al. in 2007 (3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] source
- Premisecitation
Landgraf et al. 2007 reported 340 miRNAs in 26 organs.
“This sequencing-based study reported 340 miRNAs in 26 organs.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] source
- Premisecitation
The microarray platform shows high reproducibility as evidenced by the miRQC study (5).
“We used a microarray platform for miRNA expression detection since this platform shows a high reproducibility as evidenced by the miRQC study (5).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] source
- Interpretationown data
miRNA expression is more tissue specific compared to mRNA expression.
“This result suggests that miRNA expression is more tissue specific as compared to mRNA expression.”
Quote in the paperSubstantial claim - Interpretationown data
Storage time between 1 and 14 days at 4°C has a limited influence on the overall miRNA tissue pattern.
“The duration of the storage was, however, not reflected in the clustering pattern indicating that a storage time between 1 and 14 days at 4°C has a limited influence on the overall miRNA tissue pattern.”
Quote in the paperSubstantial claim - Study design and conductown data
In this study, analysis of technical replicates of nine samples processed in different batches reached high correlation values above 0.986 for all samples.
“In our study, analysis of technical replicates of nine samples processed in different batches reached high correlation values above 0.986 for all samples.”
Quote in the paperSubstantial claim - Premisecitation
Landgraf et al. found high concordance of tissue-specific expression in humans and rodents for canonical miRNAs.
“For canonical miRNAs they found a high concordance of tissue-specific expression in humans and rodents.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] source
- Premisecitation
Previous studies observed a substantial bias introduced in NGS data by sample preparation of blood samples (10).
“In previous studies, we observed a substantial bias introduced in Next Generation Sequencing (NGS) data by sample preparation of blood samples (10).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] source
- Premisecitation
Even samples with the most degraded RNAs still preserve a tissue-specific miRNA signature (15).
“But they also clearly state that ‘even samples with the most degraded RNAs still preserve a tissue-specific miRNA signature’.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] source
Not checked in the free run.
- Interpretationown data
Inter-individual variations are smaller than inter-organ variability.
“In sum our results thus indicate that the inter-individual variations are smaller as compared to inter-organ variability.”
Quote in the paperSubstantial claim - Premisecitation
Elevated serum levels of liver-specific miR-122 have been detected in patients with drug induced liver injury, steatosis, hepatitis-B and -C infections and in patients with hepatocellular carcinoma (23-26).
“Elevated serum levels of liver-specific miR-122 have been detected in patients with drug induced liver injury, steatosis, hepatitis-B and -C infections and in patients with hepatocellular carcinoma (23–26).”
Quote in the paperNot a substantial claim0 of 4 sources checked
- May combine two claims. 35
- The quote only partly states this claim. 4
- Classified as probably not a substantial claim. 19
May combine two claims.
Findingown dataSpecific miRNAs in the heat map matched known specific miRNAs, such as miR-133a-3p and miR-133b for muscle and myocardium, or miR-9-5p, miR-219a-5p, miR-7-5p and miR-124-3p for brain and spinal cord.
“The miRNAs in this heat map matched the specific miRNAs in Figure 5 very well such as miR-133a-3p, and miR-133b for muscle and myocardium or miR-9–5p, miR-219a-5p, miR-7–5p and miR-124–3p for brain and spinal cord.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHighly specific expression of miR-205-5p, miR-514a-3p and miR-192-5p was detected in skin, testis and colon samples of one of the bodies, respectively.
“Additionally, we detected a highly specific expression of miR-205–5p, miR-514a-3p and miR-192–5p in skin, testis and colon samples of one of the bodies, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOf 10 replicated Agilent microarray measurements of the same individual, minimal correlation was 0.998 and mean/median correlation 0.999.
“Of 10 replicated Agilent microarray measurements of the same individual, we calculated 10 * 9/2 pair-wise correlations of technical replicates. Minimal correlation was 0.998 and mean/median correlation 0.999, highlighting the high degree of technical reproducibility of the array platform.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTheir results correlated well with Landgraf data, confirming specific expression of miR-122, miR-9, miR-124 and miR-7 in the respective organs.
“Overall, our results correlated well with this data, confirming specific expression of miR-122, miR-9, miR-124 and miR-7 in the respective organs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAnalysis with raw data detected an increased number of co-expressions but generally confirmed the observation based on normalized data.
“Performing the same analysis with raw data, we detected an increased number of co-expressions, but generally confirmed the observation that has been based on the normalized data.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe overall correlation of expression values of rat and human miRNAs was 0.361 (P < 10−16), indicative of significant matching of human and rat expression profiles.
“However, the overall correlation of the expression values of rat and human miRNAs was 0.361 (P < 10−16), indicative of a significant matching of human and rat expression profiles.”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Findingown dataFor miRNAs with two mature forms, -5p forms are on average 21% higher expressed than -3p forms (paired t-test P=3.6×10−10), for both quantile- and VSN-normalized data.
“Mature -5p forms were on average 21% higher expressed as compared to -3p forms (paired t-test P-value of 3.6×10−10).”
- Also stated in: § Tissue specificity of -3p and -5p mature forms · plain
“For both quantile- and VSN-normalized data, we calculated significantly higher expression of the -5p mature forms.”
Quote in the paperSubstantial claim- Also stated in: § Tissue specificity of -3p and -5p mature forms · plain
May combine two claims.
Findingown dataThe miR-378 family has the highest tissue specificity, predominantly specific for myocardium and muscle.
“Highest tissue specificity was observed for the miR-378 family, predominantly being specific for myocardium and muscle.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datamiR-449a is expressed in lung, kidney and brain.
“miR-449a in lung, kidney and brain”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataHigh correlations between technical replicates were found, with overall lowest correlations at 0.986 and 0.994 for liver and pleura, and highest correlation 0.999 for brain samples.
“Altogether, we found high correlations between these technical replicates with the overall lowest correlations at 0.986 and 0.994 observed for liver tissue and pleura, respectively. Highest correlation of 0.999 was reached for the brain samples.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSeveral miRNA families have high TSI values, including the mir-378 family whose members show high abundance in muscle tissues and myocardium.
“We found several miRNA families with high TSI values including the above-mentioned mir-378 family with most of the family members showing a high abundance in muscle tissues and the myocardium.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThese differentially abundant miRNAs had low TSI values and are not considered tissue specific.
“Although these (and similarly differentially abundant miRNAs between both individuals) miRNAs had low TSI values and are not considered tissue specific”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown datamiR-124 is expressed in different areas of the brain but not in other tissues.
“We observed expression of this miRNA in different areas of the brain but not in other tissues.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown datamiR-144 has highest expression in vein and spleen, and high expression in thyroid.
“For miR-144, we found highest expression in vein and spleen, consistent with the assumption of residual hematopoietic cells in these samples; additionally, we found high expression of this miRNA in thyroid.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown datamiRNAs with higher TSI in lung were usually specific for other organs and expressed to a very moderate limit in the lung; small variations lead to artificially high TSI values.
“Inspecting the respective miRNAs, we found that they usually were specific for other organs than the lung and expressed to a very moderate limit in the lung. Here, already small variations lead to artificially high TSI values.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFor VSN-normalized data, a similar clustering pattern was observed, but with a stronger tendency of clustering of individuals in different sub-clusters.
“For VSN-normalized data we observed a similar pattern, however, we found a stronger tendency of clustering of individuals in the different sub-clusters”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataRestricting clustering to the 100 miRNAs with highest data variance found a first main cluster containing kidney, liver, stomach and small intestine of both bodies.
“Here, we found three main clusters with the first one containing kidney, liver, stomach and small intestine of both bodies.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFew miRNAs have higher TSI in lung compared to the overall TSI, i.e., variations between organs are smaller than variations between individuals.
“These figures also indicate that few miRNAs have higher TSI in lung as compared to the overall TSI, i.e. variations between organs are smaller than variations between individuals.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data230 miRNAs matched in sequence identically between human and rat; 42 organs could be matched between the human and rat studies.
“From all miRNAs expressed in our tissue collection, 230 matched in sequence identically between human and rat. Of the tissues included in the human and rat studies, 42 organs could be matched.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHierarchical clustering of miRNAs and tissues found two major clusters; the first mainly contained nervous system tissues and muscle tissues from both bodies.
“We found two major clusters, the first of which containing mainly nervous system tissues and muscle tissues from both bodies.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataThey identified 73 miRNA pairs with tissue co-expression (Pearson correlation >0.95).
“Altogether, we identified 73 miRNA pairs with tissue co-expression.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHigh expression of miR-133b, miR-133a-3p, miR-1-3p and miR-206 was detected in both muscle samples and, with the exception of miR-206, also in both myocardial samples.
“In detail, we detected high expression of miR-133b, miR-133a-3p, miR-1–3p and miR-206 in both muscle samples and, with the exception of miR-206 also in both myocardial samples.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn clustering of 54 miRNAs with TSI > 0.9, there was no predominant clustering by species but a strong tendency of organs to cluster together.
“In this analysis we did not observe a predominant clustering in humans and rats but a strong tendency of organs to cluster together.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn 32 prostate tissues, variations between individuals were even lower than variations between organs; TSI values were significantly lower for prostate tissue (P < 10−16).
“In this analysis the variations between individuals were even lower as compared to the variations between organs. Again, TSI values were significantly lower for prostate tissue (P < 10−16).”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataClustering with the 25 miRNAs displaying TSI > 0.85 for both bodies in raw-, quantile- and VSN-normalized data found several groups of miRNAs with tissue-specific expression.
“We found several groups of miRNAs with tissue-specific expression.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn lung and heart tissue, short- and long-term degradation had an overall limited impact on the tissue specificity of miRNA profiles; only very few miRNAs were affected.
“For lung and heart tissue we investigated short- and long-term degradation, highlighting an overall limited impact on the tissue specificity of miRNA profiles. Only very few miRNAs were affected at all.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAll lung and all heart samples each clustered together in hierarchical cluster analysis.
“Hierarchical cluster analysis shows that all lung and all heart samples each cluster together (Figure 1; Supplementary Figure S1).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationmiR-205-5p is highly expressed in melanocytes and downregulated in melanoma, and is inversely correlated with melanoma progression (21).
“MiR-205–5p that is highly expressed in melanocytes and downregulated in melanoma is inverse correlated with melanoma progression (21).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe authors' previous investigation of different blood cell types indicated a complex miRNA repertoire strongly dependent on cell types.
“We recently investigated the miRNA repertoire of different blood cell types (4), already indicating a complex miRNA repertoire strongly dependent on the considered cell types.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationNGS analysis would enable detection of presently unknown miRNAs as well as miRNA isoforms that have demonstrated to target biological pathways in a cooperative manner (16).
“However, NGS analysis would enable to detect presently unknown miRNAs as well miRNAs iso-forms that have demonstrated to target biological pathways in a cooperative manner (16).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] source
Not checked in the free run.
May combine two claims.
PremisecitationAge and gender are known to influence the miRNA pattern (12).
“different donors should be of different age and gender both of which are known to influence the miRNA pattern (12).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLandgraf et al. identified miR-124 (miR-124-3p) as the third most specific miRNA in the nervous system.
“MiR-124 (miR-124–3p) was identified as the third most specific miRNA in the nervous system by Landgraf et al.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] source
Classified as probably not a substantial claim.
Study design and conductreasoningAll analyses were performed on raw data, quantile-normalized data, and variance stabilizing normalization (VSN) to account for normalization impact.
“Since the normalization may have an impact on the results, we performed all analyses on the raw data, normalized data by quantile normalization and by variance stabilizing normalization (6).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationmiR-514a-3p belongs to the miR-506 family; the mouse orthologue of miR-506, mmu-201, has been shown to be specifically expressed in reproductive tissues (3).
“MiR-514a-3p belongs to the miR-506 family; the mouse orthologue of miR-506, mmu-201, has been shown to be specifically expressed in reproductive tissues (3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLandgraf et al. identified 340 mature human miRNAs including 33 novel miRNAs not listed in miRBase version 9.1.
“They identified 340 mature human miRNAs including 33 novel miRNAs not listed in the miRBase version 9.1, which was the current version at the time of the study (17).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] source
May combine two claims.
PremisecitationLandgraf et al. detected tissue-specific expression of miR-122 in liver, miR-9, miR-124 and miR-128a/b in brain, miR-7, miR-375, miR-141 and miR-200a in pituitary gland, and miR-142, miR-144, miR-150, miR-155 and miR-223 in hematopoietic cells.
“Amongst others, Landgraf et al. detected tissue-specific expression of miR-122 in liver, of miR-9, miR-124 and miR 128a/b in brain, of miR-7, miR-375, miR-141 and miR-200a in pituitary gland and of miR-142, miR-144, miR-150, miR-155 and miR-223 in hematopoietic cells.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationmiR-144 has been found highly expressed in normal thyroid and downregulated in papillary thyroid carcinoma (18).
“Of note, miR-144 has been found highly expressed in normal thyroid and downregulated in papillary thyroid carcinoma (18).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA web-based repository was implemented to enable scientists to access and browse the data.
“We implemented a web-based repository enabling scientists to access and browse the data (https://ccb-web.cs.uni-saarland.de/tissueatlas).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataGiven data from two organs, it cannot be excluded that some tissue-specific miRNAs might be affected by degradation of the sample.
“Given the data from two organs, we however cannot exclude the possibility that some tissue-specific miRNAs might be affected by degradation of the sample.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductcitationThe applied Agilent microarray technology has been proven sensitive and reproducible in a recent comprehensive platform comparison.
“The applied Agilent microarray technology has been proven sensitive and, more important, reproducible in a recent comprehensive platform comparison (5).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataRNA integrity values (RIN) ranged between 1.8 and 2.7 for the autopsy samples.
“As expected for autopsy samples, the RNA integrity values (RIN) ranged between 1.8 and 2.7.”
Quote in the paperNot a substantial claim- Rests on an assumption: RNA integrity values between 1.8 and 2.7 in autopsy samples are sufficient for reliable miRNA profiling.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataTechnical Pearson correlation coefficients between 0.97 and 1 were achieved for technical replicates in previous studies using this technology.
“Using this technology, we achieved technical Pearson correlation coefficients of between 0.97 and 1 for technical replicates in previous studies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe most comprehensive study on tissue-specific miRNAs in humans as of now was published by Landgraf et al. in 2007 (3).
“The, as of now, most comprehensive study on tissue-specific miRNAs in humans was published by Landgraf et al. in 2007 (3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThese miRNAs are known as myomiRs that regulate key genes in muscle development (19,20).
“These miRNAs are known as myomiRs that regulate key genes in muscle development (19,20).”
Quote in the paperNot a substantial claim0 of 2 sources checkedClassified as probably not a substantial claim. May combine two claims.
PremisecitationRNA degradation due to prolonged inadequate tissue storage has a random effect on miRNAs and compromises the reliability of miRNA profiles, generating false positive deregulated miRNAs (15).
“Ibberson et al. found that RNA degradation due to prolonged inadequate tissue storage has a random effect on miRNAs and compromises the reliability of miRNA profiles, generating false positive deregulated miRNAs (15).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] source
May combine two claims.
InterpretationreasoningTSI does not acknowledge the origin of miRNAs; a value of 1 for a rat miRNA may indicate specificity for spleen and for the same miRNA specificity for brain in humans.
“While these results indicate an overall matching of miRNA abundances in humans and rats, the TSI does not acknowledge the origin of the miRNAs, i.e. a value of 1 for a rat miRNA may indicate specificity for spleen and for the same miRNA specificity for brain in humans.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLandgraf et al. sequenced 256 small RNA libraries from 26 different organ systems and cell types of humans and rodents, with ∼1000 clones each.
“They sequenced 256 small RNA libraries from 26 different organ systems and cell types of humans and rodents, with ∼1000 clone each.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenThe autopsy samples of the two male individuals provide only a snapshot of the full variability of miRNA expression.
“We are also aware that the autopsy samples of the two male individuals provide only a snapshot of the full variability of miRNA expression.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataTechnical replicates from nine randomly selected tissue samples from the second body always clustered together, showing the applied technology was suited to provide reproducible results.
“Hierarchical cluster analysis shows that the technical replicates always clustered together showing that the applied technology was suited to provide reproducible results”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA significant decrease in expression of miR-192-5p in colorectal cancer compared to normal mucosa has been reported (22).
“A significant decrease in expression of miR-192–5p in colorectal cancer compared to normal mucosa has been reported (22).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationElevated levels of circulating myomiRs (miR-1, miR-206 and miR-133a/b) have been proposed as biomarkers for heart failure and different forms of muscle dystrophy, but are also elevated after half-marathon run (27-29).
“Elevated levels of circulating myomiRs, i.e. miR-1, miR-206 and miR-133a/b, have been proposed as biomarker for heart failure and different forms of muscle dystrophy, but are also elevated after half-marathon run (27–29).”
Quote in the paperNot a substantial claim0 of 3 sources checked
The paper relies on this without support.
The two post-mortem male individuals are representative of the general human population for tissue miRNA distribution.
“Tissues analysed in this study originated from two male bodies.”
“we measured all miRNA profiles from only two different individuals to minimize inter-individual variability.”
The paper relies on this without support.
The first individual's multiple myeloma did not substantially alter the miRNA profiles of his non-tumor tissues.
“The first body was from a 65-year-old male patient, who suffered from multiple myeloma, a cancer that forms in a type of white blood cells (plasma cells).”
The paper relies on this without support.
RNA integrity values between 1.8 and 2.7 in autopsy samples are sufficient for reliable miRNA profiling.
“As expected for autopsy samples, the RNA integrity values (RIN) ranged between 1.8 and 2.7.”
The paper relies on this without support.
The majority of studies investigate differential expression in only one organ/tissue.
“Although there is ample evidence for differential miRNA expression in different human tissues, the majority of studies investigate differential expression in only one organ/tissue.”
The paper relies on this without support.
Results of studies are not easily comparable due to different identification methods and normalization strategies, limiting their value for comparison of miRNA expression in different tissues.
“Due to the different identification methods and normalization strategies, the results of these studies are not easily comparable limiting their value for comparison of miRNA expression in different tissues.”
The paper relies on this without support.
Biopsies will be mostly taken from patients with affected organs.
“biopsies will be mostly taken from patients with affected organs”
The paper relies on this without support.
High inter-individual differences can mask tissue-specific differences of miRNA abundances.
“high inter-individual differences can mask tissue-specific differences of miRNA abundances”
The paper relies on this without support.
A bias is likely introduced by multiple centres involved in tissue collections.
“a bias is likely introduced by multiple centres that are involved in tissue collections”
The paper relies on this without support.
Samples of vital organs (e.g., thalamus, spinal cord, cerebellum) are not available from biopsies.
“samples of vital organs, e.g. thalamus, spinal cord or cerebellum, are not available”
The paper relies on this without support.
RNA degradation in autopsy samples due to storage duration, advanced age, or disease status of body donors.
“with the disadvantage of RNA degradation in the samples due to the storage duration of the body and the advanced age or the disease status of the body donors”
The paper relies on this without support.
Many normalization techniques can have a substantial influence on the results.
“Many techniques that are frequently applied such as variance stabilizing normalization or quantile normalization can have a substantial influence on the results.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many miRNAs have a strong tissue-specific expression pattern and the 3' UTR of target gene plays a critical role in determining miRNA-target interaction.
“Many miRNAs have a strong tissue-specific expression pattern and 3’ UTR of target gene plays a critical role in determining the miRNA-target interaction [136, 137].”
From MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease (2016) · cites this paper as [136]
The Results section ('Frequency of miRNAs per tissue and tissue specificity of miRNAs'; page unavailable) reports 222 miRNAs with highly tissue-specific expression, supporting the first part of the sentence. Our copy does not address whether a target gene’s 3′ UTR determines miRNA–target interactions, so it does not support that part. (LLM, conf=0.90)
Experimental — accuracy not yet measuredWell-described brain-specific miRNAs include mir-9, mir-124, mir-219, mir-338, and miRNAs missing from existing catalogs include mir-666, mir-878, mir-433.
“We identified both well-described brain-specific miRNAs, such as mir-9, mir-124, mir-219, mir-338 (16, 24, 33), as well as those which are missing from existing catalogs, such as mir-666, mir-878, mir-433, etc.”
From A mouse tissue atlas of small noncoding RNA (2020) · cites this paper as [33]
These and subsequent studies have not unraveled cellular microRNA expression.
“While providing valuable insights into the relationship of microRNA expression and disease (Lu et al. 2005), these and subsequent studies (Cheng et al. 2015; Ludwig et al. 2016) have not unraveled cellular microRNA expression.”
From Toward the human cellular microRNAome (2017) · cites this paper as Ludwig et al. 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
miR-122-5p is called exclusive to liver despite detection elsewhere
MinorThe results call miR-122-5p exclusively expressed in liver, whereas the discussion reports its expression in three other tissue types.
“miR-122–5p, miR-7–5p and miR-205–5p were each exclusively expressed in liver, pituitary gland and skin, respectively.”
“Our study, however, also identified low expression of miR-122–5p in spleen, gall bladder and veins.”
Human-rat TSI correlation has two stated P-values
MinorThe abstract gives P = 10−8, while the results give P = 9 × 10−8 for the human-rat TSI correlation.
“MiRNAs TSI values of human tissues were significantly (P = 10−8) correlated with those of rats;”
“For all these miRNAs and organs, we calculated the TSI values in human and rat, showing an overall correlation of 0.362 (P-value of 9 × 10−8).”
The 16 additional lung biopsies are described as both normal and cancer tissue
MinorThe methods describe these biopsies as normal lung tissue, but the additional-data section calls them lung cancer tissues.
“For 16 normal tissue biopsies from different individuals, the miRNA expression intensity was determined as for the two bodies and the samples from the degradation analysis.”
“In addition to the 44 tissue samples from the degradation and reproducibility analysis, the 16 individual lung cancer tissues and the 61 tissues from two bodies newly measured for this study, we searched the literature for other studies where normal tissues have been profiled.”
Co-expression correlations are identified as both Pearson and Spearman
MinorThe methods and Figure 6B identify the co-expression measure as Spearman correlation, but the results say the 0.95 cutoff was applied to Pearson correlation.
“We used a high correlation cut-off and considered only miRNA-pairs with Pearson correlation exceeding 0.95.”
“Each miRNA pair connected by an edge has co-expression across all samples with Spearman correlation coefficient above 0.95.”
Cites
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288 · see citing works
miRBase: microRNA sequences, targets and gene nomenclature
Griffiths‐Jones, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gkj112 · Cited by 4,713 · see citing works
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626 · see citing works
Huber, W., von Heydebreck, A., Sültmann, H., Poustka, A., & Vingron, M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.suppl_1.s96 · Cited by 2,440 · see citing works
Yanai, I., Benjamin, H., Shmoish, M., Chalifa-Caspi, V., Shklar, M., Ophir, R., Bar-Even, A., Horn-Saban, S., Safran, M., Domany, E., et al. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti042 · Cited by 1,300 · see citing works
The Human Protein Atlas—a tool for pathology
Pontén, F., Jirström, K., & Uhlén, M. (2008) · The Journal of Pathology · doi:10.1002/path.2440 · Cited by 1,126 · see citing works
Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study
Mestdagh, P., Hartmann, N., Baeriswyl, L., Andreasen, D., Bernard, N., Chen, C., Cheo, D., D'Andrade, P., DeMayo, M., Dennis, L., et al. (2014) · Nature Methods · doi:10.1038/nmeth.3014 · Cited by 619 · see citing works
Pirola, C. J., Fernández Gianotti, T., Castaño, G. O., Mallardi, P., San Martino, J., Mora Gonzalez Lopez Ledesma, M., Flichman, D., Mirshahi, F., Sanyal, A. J., & Sookoian, S. (2015) · Gut · doi:10.1136/gutjnl-2014-306996 · Cited by 507 · see citing works
Xu, J., Wu, C., Che, X., Wang, L., Yu, D., Zhang, T., Huang, L., Li, H., Tan, W., Wang, C., et al. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20712 · Cited by 466 · see citing works
MicroRNAs and their isomiRs function cooperatively to target common biological pathways
Cloonan, N., Wani, S., Xu, Q., Gu, J., Lea, K., Heater, S., Barbacioru, C., Steptoe, A. L., Martin, H. C., Nourbakhsh, E., et al. (2011) · Genome Biology · doi:10.1186/gb-2011-12-12-r126 · Cited by 345 · see citing works
Petryszak, R., Burdett, T., Fiorelli, B., Fonseca, N. A., Gonzàlez-Porta, M., Hastings, E., Huber, W. K., Jupp, S., Keays, M., Kryvych, N., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1270 · Cited by 337 · see citing works
MicroRNAs: novel regulators in cardiac development and disease
Thum, T., Catalucci, D., & Bauersachs, J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn137 · Cited by 299 · see citing works
miRNAs as serum biomarkers for Duchenne muscular dystrophy
Cacchiarelli, D., Legnini, I., Martone, J., Cazzella, V., D'Amico, A., Bertini, E., & Bozzoni, I. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100133 · Cited by 248 · see citing works
Akat, K. M., Moore-McGriff, D., Morozov, P., Brown, M., Gogakos, T., Correa Da Rosa, J., Mihailovic, A., Sauer, M., Ji, R., Ramarathnam, A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401724111 · Cited by 221 · see citing works
MicroRNAs in Skeletal and Cardiac Muscle Development
Callis, T. E., Chen, J.-F., & Wang, D.-Z. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0556 · Cited by 138 · see citing works
Swierniak, M., Wojcicka, A., Czetwertynska, M., Stachlewska, E., Maciag, M., Wiechno, W., Gornicka, B., Bogdanska, M., Koperski, L., de la Chapelle, A., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1214 · Cited by 120 · see citing works
Influence of the Confounding Factors Age and Sex on MicroRNA Profiles from Peripheral Blood
Meder, B., Backes, C., Haas, J., Leidinger, P., Stähler, C., Großmann, T., Vogel, B., Frese, K., Giannitsis, E., Katus, H. A., et al. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.224238 · Cited by 106 · see citing works
Self-citationPrognostic Significance of miR-215 in Colon Cancer
Karaayvaz, M., Pal, T., Song, B., Zhang, C., Georgakopoulos, P., Mehmood, S., Burke, S., Shroyer, K., & Ju, J. (2011) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2011.06.002 · Cited by 91 · see citing works
RNA degradation compromises the reliability of microRNA expression profiling
Ibberson, D., Benes, V., Muckenthaler, M. U., & Castoldi, M. (2009) · BMC Biotechnology · doi:10.1186/1472-6750-9-102 · Cited by 90 · see citing works
Circulating miR-1, miR-133a, and miR-206 levels are increased after a half-marathon run
Gomes, C. P. C., Oliveira-Jr, G. P., Madrid, B., Almeida, J. A., Franco, O. L., & Pereira, R. W. (2014) · Biomarkers · doi:10.3109/1354750x.2014.952663 · Cited by 88 · see citing works
Krauskopf, J., Caiment, F., Claessen, S. M., Johnson, K. J., Warner, R. L., Schomaker, S. J., Burt, D. A., Aubrecht, J., & Kleinjans, J. C. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfu232 · Cited by 85 · see citing works
Lv, Y., Ma, K., Zhang, H., He, M., Zhang, P., Shen, Y., Jiang, N., Ma, D., & Chen, L. (2014) · Journal of Forensic Sciences · doi:10.1111/1556-4029.12447 · Cited by 76 · see citing works
Loss of microRNA-205 expression is associated with melanoma progression
Liu, S., Tetzlaff, M. T., Liu, A., Liegl-Atzwanger, B., Guo, J., & Xu, X. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.62 · Cited by 67 · see citing works
The human miRNA repertoire of different blood compounds
Leidinger, P., Backes, C., Meder, B., Meese, E., & Keller, A. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-474 · Cited by 62 · see citing works
Self-citationBias in High-Throughput Analysis of miRNAs and Implications for Biomarker Studies
Backes, C., Sedaghat‐Hamedani, F., Frese, K., Hart, M., Ludwig, N., Meder, B., Meese, E. U., & Keller, A. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03376 · Cited by 58 · see citing works
Self-citationEffects of Postmortem Interval on Biomolecule Integrity in the Brain
Nagy, C., Maheu, M., Lopez, J. P., Vaillancourt, K., Cruceanu, C., Gross, J. A., Arnovitz, M., Mechawar, N., & Turecki, G. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000190 · Cited by 58 · see citing works
Differences in serum microRNA profiles in hepatitis B and C virus infection
Akamatsu, S., Hayes, C. N., Tsuge, M., Miki, D., Akiyama, R., Abe, H., Ochi, H., Hiraga, N., Imamura, M., Takahashi, S., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2014.10.017 · Cited by 57 · see citing works
miRNA expression atlas in male rat
Minami, K., Uehara, T., Morikawa, Y., Omura, K., Kanki, M., Horinouchi, A., Ono, A., Yamada, H., Ohno, Y., & Urushidani, T. (2014) · Scientific Data · doi:10.1038/sdata.2014.5 · Cited by 55 · see citing works
Backes, C., Leidinger, P., Altmann, G., Wuerstle, M., Meder, B., Galata, V., Mueller, S. C., Sickert, D., Stähler, C., Meese, E., et al. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b02043 · Cited by 24 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
Saliminejad, K., Khorshid, H. R. K., Fard, S. S., & Ghaffari, S. H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27486 · Cited by 2,047 · see citing works
Emerging concepts of miRNA therapeutics: from cells to clinic
Diener, C., Keller, A., & Meese, E. U. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.02.006 · Cited by 981 · see citing works
Self-citationHuang, H., Lin, Y.-C.-D., Cui, S., Tang, Y., Tang, Y., Xu, J., Bao, J., Li, Y., Wen, J., Zuo, H., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1079 · Cited by 979 · see citing works
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Mori, M. A., Ludwig, R. G., García-Martín, R., Brandão, B. B., & Kahn, C. R. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.011 · Cited by 970 · see citing works
Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
Kahn, C. R., Wang, G., & Lee, K. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129187 · Cited by 656 · see citing works
An integrated expression atlas of miRNAs and their promoters in human and mouse
The FANTOM Consortium, de Rie, D., Abugessaisa, I., Alam, T., Arner, E., Arner, P., Ashoor, H., Åström, G., Babina, M., Bertin, N., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3947 · Cited by 561 · see citing works
An estimate of the total number of true human miRNAs
Alles, J., Fehlmann, T., Fischer, U., Backes, C., Galata, V., Minet, M., Hart, M., Abu-Halima, M., Grässer, F. A., Lenhof, H.-P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz097 · Cited by 555 · see citing works
Self-citationMolecular Biomarkers in Cancer
Sarhadi, V. K., & Armengol, G. (2022) · Biomolecules · doi:10.3390/biom12081021 · Cited by 498 · see citing works
Cardoso, A. L., Fernandes, A. M. A., Aguilar‐Pimentel, J. A., de Angelis, M. H., Guedes, J. R., Brito, M. A., Ortolano, S., Pani, G., Athanasopoulou, S., Gonos, E. S., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.004 · Cited by 471 · see citing works
MicroRNA Regulation of RNA Virus Replication and Pathogenesis
Trobaugh, D. W., & Klimstra, W. B. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.11.003 · Cited by 391 · see citing works
Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies
Berg, K. C. G., Eide, P. W., Eilertsen, I. A., Johannessen, B., Bruun, J., Danielsen, S. A., Bjørnslett, M., Meza‐Zepeda, L. A., Eknæs, M., Lind, G. E., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0691-y · Cited by 382 · see citing works
Trials and Tribulations of MicroRNA Therapeutics
Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031469 · Cited by 381 · see citing works
Recent Advances in miRNA Delivery Systems
Dasgupta, I., & Chatterjee, A. (2021) · Methods and Protocols · doi:10.3390/mps4010010 · Cited by 312 · see citing works
The evolving role of investigative toxicology in the pharmaceutical industry
Pognan, F., Beilmann, M., Boonen, H. C. M., Czich, A., Dear, G. J., Hewitt, P. G., Mow, T. J., Oinonen, T., Roth, A. B., Steger‐Hartmann, T., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00633-x · Cited by 274 · see citing works
miRPathDB 2.0: a novel release of the miRNA Pathway Dictionary Database
Kehl, T., Kern, F., Backes, C., Fehlmann, T., Stöckel, D., Meese, E. U., Lenhof, H., & Keller, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1022 · Cited by 244 · see citing works
Self-citationmiRNAs and NAFLD: from pathophysiology to therapy
Gjorgjieva, M., Sobolewski, C., Dolicka, D., de Sousa, M. C., & Foti, M. (2019) · Gut · doi:10.1136/gutjnl-2018-318146 · Cited by 242 · see citing works
Large Differences in Small RNA Composition Between Human Biofluids
Godoy, P. M., Bhakta, N. R., Barczak, A. J., Çakmak, H., Fisher, S. J., MacKenzie, T. C., Patel, T. C., Price, R. W., Smith, J. F., Woodruff, P. G., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.014 · Cited by 239 · see citing works
Complexities of post-transcriptional regulation and the modeling of ceRNA crosstalk
Smillie, C. L., Sirey, T., & Ponting, C. P. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1447542 · Cited by 238 · see citing works
miRTargetLink 2.0—interactive miRNA target gene and target pathway networks
Kern, F., Aparicio-Puerta, E., Li, Y., Fehlmann, T., Kehl, T., Wagner, V., Ray, K., Ludwig, N., Lenhof, H.-P., Meese, E., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab297 · Cited by 203 · see citing works
Self-citationInterplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases
Konovalova, J., Gerasymchuk, D., Parkkinen, I., Chmielarz, P., & Domanskyi, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236055 · Cited by 199 · see citing works
MiRNAs: Biology, Biogenesis, their Web-based Tools, and Databases
Tafrihi, M., & Hasheminasabgorji, E. (2018) · MicroRNA · doi:10.2174/2211536607666180827111633 · Cited by 196 · see citing works
MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside
To, K. K. W., Tong, C. W. S., Wu, M., & Cho, W. C. S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i27.2949 · Cited by 195 · see citing works
Reexamining assumptions about miRNA-guided gene silencing
Kilikevicius, A., Meister, G., & Corey, D. R. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1256 · Cited by 194 · see citing works
miEAA 2.0: integrating multi-species microRNA enrichment analysis and workflow management systems
Kern, F., Fehlmann, T., Solomon, J., Schwed, L., Grammes, N. L., Backes, C., Keuren‐Jensen, K. R. V., Craig, D. W., Meese, E. U., & Keller, A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa309 · Cited by 192 · see citing works
Self-citationLoganathan, T., & Doss, C. G. P. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-022-00947-4 · Cited by 190 · see citing works
MicroRNA Signatures as Future Biomarkers for Diagnosis of Diabetes States
Vasu, S., Kumano, K., Darden, C. M., Rahman, I., Lawrence, M. C., & Naziruddin, B. (2019) · Cells · doi:10.3390/cells8121533 · Cited by 181 · see citing works
Hordeaux, J., Buza, E. L., Jeffrey, B., Song, C., Jahan, T., Yuan, Y., Zhu, Y., Bell, P., Li, M., Chichester, J. A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aba9188 · Cited by 174 · see citing works
Sheinerman, K. S., Toledo, J. B., Tsivinsky, V. G., Irwin, D. J., Grossman, M., Weintraub, D. A., Hurtig, H. I., Chen‐Plotkin, A. S., Wolk, D. A., McCluskey, L. F., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0316-0 · Cited by 168 · see citing works
MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct
Jain, R., Frederick, J. P., Huang, E. Y., Burke, K. E., Mauger, D. M., Andrianova, E. A., Farlow, S. J., Siddiqui, S., Pimentel, J., Cheung-Ong, K., et al. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0734 · Cited by 164 · see citing works
Galvão-Lima, L. J., de Morais, A. H. F., Valentim, R. A. D. M., & Barreto, É. J. S. D. S. (2021) · BioMedical Engineering OnLine · doi:10.1186/s12938-021-00857-9 · Cited by 161 · see citing works
MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
Kahraman, M., Röske, A., Laufer, T., Fehlmann, T., Backes, C., Kern, F., Kohlhaas, J., Schrörs, H., Saiz, A., Zabler, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29917-2 · Cited by 158 · see citing works
Self-citationFetal Bovine Serum RNA Interferes with the Cell Culture derived Extracellular RNA
Wei, Z., Batagov, A. O., Carter, D. R. F., & Krichevsky, A. M. (2016) · Scientific Reports · doi:10.1038/srep31175 · Cited by 155 · see citing works
Toward the human cellular microRNAome
McCall, M. N., Kim, M.-S., Adil, M., Patil, A. H., Lu, Y., Mitchell, C. J., Leal-Rojas, P., Xu, J., Kumar, M., Dawson, V. L., et al. (2017) · Genome Research · doi:10.1101/gr.222067.117 · Cited by 151 · see citing works
Editorial focus: understanding off-target effects as the key to successful RNAi therapy
Bartoszewski, R., & Sikorski, A. F. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0196-3 · Cited by 150 · see citing works
MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior
Allen, L., & Dwivedi, Y. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0597-8 · Cited by 148 · see citing works
Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients
de Gonzalo‐Calvo, D., Benitez, I. D., Pinilla, L., Carratalá, A., Moncusí‐Moix, A., Gort‐Paniello, C., Molinero, M., González, J., Torres, G., Bernal, M., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.05.004 · Cited by 147 · see citing works
Millan, M. J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.004 · Cited by 146 · see citing works
Mechanisms of tissue and cell-type specificity in heritable traits and diseases
Hekselman, I., & Yeger‐Lotem, E. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0200-9 · Cited by 146 · see citing works
miRNATissueAtlas2: an update to the human miRNA tissue atlas
Keller, A., Gröger, L., Tschernig, T., Solomon, J., Laham, O., Schaum, N., Wagner, V., Kern, F., Schmartz, G. P., Li, Y., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab808 · Cited by 143 · see citing works
Self-citationMartínez, C., Rodiño‐Janeiro, B. K., Lobo, B., Stanifer, M. L., Klaus, B., Granzow, M., González-Castro, A. M., Salvo‐Romero, E., Alonso, C., Pigrau, M., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311477 · Cited by 143 · see citing works
Farina, F. M., Hall, I. F., Serio, S., Zani, S., Climent, M., Salvarani, N., Carullo, P., Civilini, E., Condorelli, G., Elia, L., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316489 · Cited by 142 · see citing works
Fehlmann, T., Kahraman, M., Ludwig, N., Backes, C., Galata, V., Keller, V., Geffers, L., Mercaldo, N. D., Hornung, D., Weis, T., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0001 · Cited by 141 · see citing works
Self-citationCritical Role of microRNA-21 in the Pathogenesis of Liver Diseases
Zhang, T., Yang, Z., Kusumanchi, P., Han, S., & Liangpunsakul, S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00007 · Cited by 139 · see citing works
Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer
Wang, H., Meng, Q., Qian, J., Li, M., Gu, C., & Yang, Y. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108123 · Cited by 131 · see citing works
Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis
Magen, I., Yacovzada, N., Yanowski, E., Coenen-Stass, A. M. L., Großkreutz, J., Lu, C., Greensmith, L., Malaspina, A., Fratta, P., & Hornstein, E. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00936-z · Cited by 127 · see citing works
Ketogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities
Talib, W. H., Mahmod, A. I., Kamal, A., Rashid, H. M., Alashqar, A. M. D., Khater, S. H., Jamal, D., & Waly, M. I. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43020042 · Cited by 126 · see citing works
Role of miR-223 in the pathophysiology of liver diseases
Ye, D., Zhang, T., Lou, G., & Liu, Y. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0153-7 · Cited by 125 · see citing works
D’Souza, R. F., Woodhead, J. S. T., Zeng, N., Blenkiron, C., Merry, T. L., Cameron‐Smith, D., & Mitchell, C. J. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00138.2018 · Cited by 123 · see citing works
Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry
Wang, P., Zhou, Y., & Richards, M. (2021) · Theranostics · doi:10.7150/thno.62642 · Cited by 123 · see citing works
The roles of microRNAs in mouse development
DeVeale, B., Swindlehurst-Chan, J., & Blelloch, R. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00309-5 · Cited by 121 · see citing works
Bernstein, D. L., Zuluaga-Ramirez, V., Gajghate, S., Reichenbach, N. L., Polyak, B., Persidsky, Y., & Rom, S. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19882264 · Cited by 120 · see citing works
A mouse tissue atlas of small noncoding RNA
Isakova, A., Fehlmann, T., Keller, A., & Quake, S. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002277117 · Cited by 119 · see citing works
Self-citationThe microRNA-29 family: role in metabolism and metabolic disease
Dalgaard, L. T., Sørensen, A. E., Hardikar, A. A., & Joglekar, M. V. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00051.2022 · Cited by 116 · see citing works
Quantitative analysis of Y-Chromosome gene expression across 36 human tissuesPreprint
Godfrey, A. K., Naqvi, S., Chmátal, L., Chick, J. M., Mitchell, R. N., Gygi, S. P., Skaletsky, H., & Page, D. C. (2020) · Genome Research · doi:10.1101/gr.261248.120 · Cited by 116 · see citing works
Raoof, R. M., Bauer, S., Naggar, H. E., Connolly, N. M. C., Brennan, G. P., Brindley, E., Hill, T., McArdle, H., Spain, E., Forster, R. J., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.068 · Cited by 111 · see citing works
Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
Hoffmann, M. D., Aschenbrenner, S., Große, S., Rapti, K., Domenger, C., Fakhiri, J., Mastel, M., Börner, K., Eils, R., Grimm, D., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz271 · Cited by 109 · see citing works
Brito‐Rocha, T., Constâncio, V., Henrique, R., & Jerónimo, C. (2023) · Cells · doi:10.3390/cells12060935 · Cited by 107 · see citing works
Circulating microRNAs as potential diagnostic biomarkers for osteoporosis
Mandourah, A. Y., Ranganath, L. R., Barraclough, R., Vinjamuri, S., Hof, R. V., Hamill, S., Czanner, G., Dera, A. A., Wang, D., & Barraclough, D. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-26525-y · Cited by 106 · see citing works
MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis
Ricci, C., Marzocchi, C., & Battistini, S. (2018) · Cells · doi:10.3390/cells7110219 · Cited by 106 · see citing works
Martínez‐Ibarra, A., Martínez‐Razo, L. D., Vázquez-Martínez, E. R., Martínez-Cruz, N., Flores‐Ramírez, R., García-Gómez, E., López, M., Ortega-González, C., Camacho‐Arroyo, I., & Cerbón, M. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133343 · Cited by 104 · see citing works
miRCarta: a central repository for collecting miRNA candidates
Backes, C., Fehlmann, T., Kern, F., Kehl, T., Lenhof, H., Meese, E. U., & Keller, A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx851 · Cited by 103 · see citing works
Self-citationGiraldez, M. D., Spengler, R. M., Etheridge, A., Goicochea, A. J., Tuck, M. K., Choi, S. W., Galas, D. J., & Tewari, M. (2019) · The EMBO Journal · doi:10.15252/embj.2019101695 · Cited by 103 · see citing works
Salivary MicroRNAs: Diagnostic Markers of Mild Traumatic Brain Injury in Contact-Sport
Pietro, V. D., Porto, E., Ragusa, M., Barbagallo, C., Davies, D. J., Forcione, M., Logan, A., Pietro, C. D., Purrello, M., Grey, M. J., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00290 · Cited by 99 · see citing works
Common diseases alter the physiological age-related blood microRNA profile
Fehlmann, T., Lehallier, B., Schaum, N., Hahn, O., Kahraman, M., Li, Y., Grammes, N. L., Geffers, L., Backes, C., Balling, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19665-1 · Cited by 99 · see citing works
Self-citationLu, Q., Powles, R. L., Abdallah, S., Ou, D., Wang, Q., Hu, Y., Lu, Y., Liu, W., Li, B., Mukherjee, S., et al. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006933 · Cited by 97 · see citing works
Diversity and signature of small RNA in different bodily fluids using next generation sequencing
El-Mogy, M., Lam, B., Haj-Ahmad, T. A., McGowan, S., Yu, D. L., Nosal, L., Rghei, N., Roberts, P., & Haj-Ahmad, Y. (2018) · BMC Genomics · doi:10.1186/s12864-018-4785-8 · Cited by 94 · see citing works
The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs
Puckett, D. L., Alquraishi, M. I., Chowanadisai, W., & Bettaieb, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031171 · Cited by 93 · see citing works
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals
Tarallo, S., Ferrero, G., Filippis, F. D., Francavilla, A., Pasolli, E., Panero, V., Cordero, F., Segata, N., Grioni, S., Pensa, R. G., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-325168 · Cited by 91 · see citing works
Distribution of microRNA biomarker candidates in solid tissues and body fluids
Fehlmann, T., Ludwig, N., Backes, C., Meese, E. U., & Keller, A. (2016) · RNA Biology · doi:10.1080/15476286.2016.1234658 · Cited by 90 · see citing works
Self-citationNair, V. D., Ge, Y., Li, S., Pinças, H., Jain, N., Seenarine, N., Amper, M. A. S., Goodpaster, B. H., Walsh, M. J., Coen, P. M., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00605 · Cited by 90 · see citing works
Bianchi, M., Renzini, A., Adamo, S., & Moresi, V. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040840 · Cited by 89 · see citing works
Hücker, S. M., Fehlmann, T., Werno, C., Weidele, K., Lüke, F., Schlenska‐Lange, A., Klein, C. A., Keller, A., & Kirsch, S. (2021) · Nature Communications · doi:10.1038/s41467-021-24611-w · Cited by 89 · see citing works
Self-citationmiR-323a regulates ERBB4 and is involved in depression
Fiori, L. M., Kos, A., Lin, R., Théroux, J.-F., Lopez, J. P., Kühne, C., Eggert, C., Holzapfel, M., Huettl, R.-E., Mechawar, N., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00953-7 · Cited by 88 · see citing works
Sebastiani, G., Guarino, E., Grieco, G. E., Formichi, C., Poggi, C. D., Ceccarelli, E., & Dotta, F. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00345 · Cited by 88 · see citing works
Recent progress of SERS optical nanosensors for miRNA analysis
Sun, Y., Shi, L., Mi, L., Guo, R., & Li, T. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00280a · Cited by 88 · see citing works
The dark side of foetal bovine serum in extracellular vesicle studies
Urzì, O., Bagge, R. O., & Crescitelli, R. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12271 · Cited by 88 · see citing works
Denk, J., Oberhauser, F., Kornhuber, J., Wiltfang, J., Fassbender, K. C., Schroeter, M. L., Volk, A. E., Diehl‐Schmid, J., Prudlo, J., Danek, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197329 · Cited by 87 · see citing works
miRNA assays in the clinical laboratory: workflow, detection technologies and automation aspects
Kappel, A., & Keller, A. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0467 · Cited by 87 · see citing works
Self-citationCirculating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges
Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147974 · Cited by 85 · see citing works
Understanding Epigenetics in the Neurodegeneration of Alzheimer’s Disease: SAMP8 Mouse Model
Griñán‐Ferré, C., Corpas, R., Puigoriol‐Illamola, D., Palomera‐Ávalos, V., Sanfeliu, C., & Pallàs, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170664 · Cited by 83 · see citing works
Abdalla, M. A., Deshmukh, H., Atkin, S. L., & Sathyapalan, T. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118174 · Cited by 83 · see citing works
Centa, A., Fonseca, A. S., Ferreira, S. G. D. S., de Azevedo, M. L. V., de Paula, C. B. V., Nagashima, S., Souza, C. M., Miggiolaro, A. F. R. D. S., Baena, C. P., de Noronha, L., et al. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00457.2020 · Cited by 82 · see citing works
The microRNAs Regulating Vascular Smooth Muscle Cell Proliferation: A Minireview
Wang, D., & Atanasov, A. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020324 · Cited by 81 · see citing works
Bottani, M., Banfi, G., & Lombardi, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101661 · Cited by 81 · see citing works
Characterization of distinct circular RNA signatures in solid tumors
Wang, C., Liu, W., Tan, S., Zhou, J., Xu, X., Ming, Y., Cheng, J., Li, J., Zeng, Z., Zuo, Y., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01546-4 · Cited by 81 · see citing works
New insights into the interplay between miRNAs and autophagy in the aging of intervertebral discs
Lan, T., Shiyu-Hu, Shen, Z., Yan, B., & Chen, J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101227 · Cited by 80 · see citing works
Validation of human microRNA target pathways enables evaluation of target prediction tools
Kern, F., Krammes, L., Danz, K., Diener, C., Kehl, T., Küchler, O., Fehlmann, T., Kahraman, M., Rheinheimer, S., Aparicio‐Puerta, E., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1161 · Cited by 79 · see citing works
Self-citationRishik, S., Hirsch, P., Grandke, F., Fehlmann, T., & Keller, A. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1036 · Cited by 79 · see citing works
Self-citationMolecular Pathology of Lung CancerPreprint
Saller, J. J., & Boyle, T. A. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037812 · Cited by 79 · see citing works
Elevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke
Sørensen, S. S., Nygaard, A., Carlsen, A. L., Heegaard, N. H. H., Bak, M., & Christensen, T. (2017) · Biomarker Research · doi:10.1186/s40364-017-0104-9 · Cited by 78 · see citing works
Label-Free Detection of miRNA Using Surface-Enhanced Raman Spectroscopy
Li, D., Xia, L., Zhou, Q., Wang, L., Chen, D., Gao, X. Q., & Li, Y. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03335 · Cited by 78 · see citing works
Machine Learning to Detect Alzheimer’s Disease from Circulating Non-Coding RNAs
Ludwig, N., Fehlmann, T., Kern, F., Gogol, M., Maetzler, W., Deutscher, S., Gurlit, S., Schulte, C., von Thaler, A., Deuschle, C., et al. (2019) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.09.004 · Cited by 77 · see citing works
Self-citationImplications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting
Rad, S. M. A. H., & McLellan, A. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134807 · Cited by 77 · see citing works
Yılmaz, Ş. G., Erdal, M. E., Özge, A., & Sungur, M. A. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0099 · Cited by 77 · see citing works
Fortunato, O., Borzi, C., Milione, M., Centonze, G., Conte, D., Boeri, M., Verri, C., Moro, M., Facchinetti, F., Andriani, F., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31988 · Cited by 76 · see citing works
Challenges in endometriosis miRNA studies — From tissue heterogeneity to disease specific miRNAs
Saare, M., Rekker, K., Laisk, T., Rahmioğlu, N., Zondervan, K. T., Salumets, A., Götte, M., & Peters, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.018 · Cited by 76 · see citing works
Hou, G., Harley, I. T. W., Lu, X., Zhou, T., Xu, N., Yao, C., Qin, Y., Ouyang, Y., Ma, J., Zhu, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20460-1 · Cited by 75 · see citing works
Delivery of therapeutic miRNA using polymer-based formulation
Ban, E., Kwon, T.-H., & Kim, A. (2019) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00645-y · Cited by 75 · see citing works
MiR‐9‐5p protects from kidney fibrosis by metabolic reprogramming
Fierro‐Fernández, M., Miguel, V., Márquez‐Expósito, L., Nuevo‐Tapioles, C., Herrero, J. I., Blanco, E. M., Tituaña, J., Castillo, C., Cannata, P., Monsalve, M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901599rr · Cited by 74 · see citing works
El‐Achkar, T. M., Eadon, M. T., Menon, R., Lake, B. B., Sigdel, T. K., Alexandrov, T., Parikh, S. V., Zhang, G., Dobi, D., Dunn, K. W., et al. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00104.2020 · Cited by 73 · see citing works
- Authors
- Ludwig, N., Leidinger, P., Becker, K., Backes, C., Fehlmann, T., Pallasch, C., Rheinheimer, S., Meder, B., Stähler, C., Meese, E., & Keller, A.
- Affiliations
- Saarland University (DE)
- Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE)
- University Hospital Heidelberg (DE)
- Siemens Healthineers (Germany) (DE)
- Corresponding author
- Keller, Andreas
- ORCID
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-02-25
- Volume
- 44
- Issue
- 8
- Pages
- 3865-3877
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4856985
- OpenAlex
- W2288482887
- Semantic Scholar
- dc9823564677f04a2e1f18bb6ed9f2c7fef80a0e
- Cited by
- 968
- References
- 29
- Citations by year
- 2026: 45 · 2025: 73 · 2024: 93 · 2023: 97 · 2022: 104 · 2021: 138 · 2020: 141 · 2019: 109 · 2018: 88 · 2017: 61 · 2016: 17 · 2015: 1
- FWCI
- 32.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Universität des Saarlandes
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Molecular Biology Research
- Keywords
- microRNA expression, human tissue atlas, miRNA abundance, miR-150, brain, lung, prostate, heart, rat comparison, postmortem tissue, web-based repository
- MeSH terms
- Adult, Aged, Animals, Humans, Male, Organ Specificity, Tissue Distribution, Reproducibility of Results, Databases, Nucleic Acid, MicroRNAs, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review